Management of abnormal uterine bleeding;Ursachen und therapie von uterinen blutungsstörungen

Zentralblatt fur Gynakologie

Volumn 128, Issue 4, 2006, Pages 196-201

  Gaetje, R ^a   Scharl, A ^b   Kaufmann, M ^a   Ahr, A ^c  

^a GOETHE UNIVERSITY   (Germany)

^b KLINIKUM ST MARIEN   (Germany)

^c Gynäkologische Praxis am Ziegelturm ^*  (Germany)

Author keywords

Endometrial ablation; Hormones; Hysterectomy; Myomectomy

Indexed keywords

ANTIFIBRINOLYTIC AGENT; ESTROGEN; GESTAGEN; LEVONORGESTREL; NONSTEROID ANTIINFLAMMATORY AGENT;

ADENOMYOSIS; BLEEDING DISORDER; BLOOD CLOTTING DISORDER; CLIMACTERIUM; DEMOGRAPHY; DRUG EFFICACY; ENDOMETRIUM ABLATION; ENDOMETRIUM POLYP; GYNECOLOGIC DISEASE; HORMONE ACTION; HUMAN; HYSTERECTOMY; MYOMA; PREMENOPAUSE; REVIEW; UTERUS BLEEDING;

ALGORITHMS; CATHETER ABLATION; CONTRACEPTIVE AGENTS, FEMALE; EMBOLIZATION, THERAPEUTIC; ENDOMETRIUM; FEMALE; HUMANS; LEVONORGESTREL; MENOPAUSE; UTERINE HEMORRHAGE;

EID: 33746656617     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-933448     Document Type: Review

References (58)

1. Hatasaka H. The Evaluation of abnormal uterine bleeding. Clin Obstet Gynecol 2005; 48: 258-273
2. Muzaffar M, Akhtar KA, Yasmin S, Mahmood-Ur-Rehman, Iqbal W, Khan MA. Menstrual irregularities with excessive blodd loss: a clinico-pathological correlation. J Pak med Assoc 2005; 55: 486-489
3. Strowitzki T. Praktisches Vorgehen bei gestörter Ovarfunktion und mit ihr assoziierter Phänomene. In: Leidenberger F, Strowitzki T, Ortmann O (Hrsg). Klinische Endokrinologie. Springer, Heidelberg 2005; 559-634
4. Singh RH, Blumenthal P. Hormonal management of abnormal uterine bleeding. Clin Obstet Gynecol 2005; 48: 337-352
5. Lethaby AE, Cooke I, Ress M. Progesterone or progesterone-releasing intrauterine systems for heavy menstrual bleeding (Cochrane review). In: The Cochrane Library. Issue 4. ISSN 1464-780X 2005
6. Wildermeersch D, Rowe PJ. Assessment of menstrual blood loss in Belgian users of new T-shaped levonorgestrel-releasing intrauterine system. Contraception 2005; 71: 470-473
7. Kingman CE, Kudir RA, Lee CA, Economides DL. The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleedung disorders. BJOG 2004; 111: 1425-1428
8. Mercorio F, De Simone R, Spiezio Sardo A, Cerrota G, Bifulco G, Vanacore F, Nappi C The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia. Contraception 2003; 67: 277-280
9. Kuhl H. Pharmocology of estrogens anf progesterones: influence of different routes of administration. Climacteric 2005; 8 (Suppl 1): 3-63
10. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy mentrual bleeding (Cochrane review). In: The Cochrane Library. Issue 4. ISSN 1464-780X 2005
11. Lethaby A, Augood C, Duckitt K. Nonsteroidal anti-inflammytory drugs for heavy menstrual bleeding (Cochrane review). In: The Cochrane Library. Issue 4. ISSN 1464-780X 2005
12. Pelage JP, Jacob D, Fazel A, Namur J, Laurent A, Rymer R, Le Dref O. Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience. Radiology 2005; 234: 948-953
13. Kim MD, Won JW, Lee DY, Ahn CS. Uterine artery embolization for adenomyosis without fibroids. Clin Radiol 2004; 59: 520-526
14. Bai SW, Jang JB, Lee DY, Jeong KA, Kim SK, Park KH. Uterine artery embolization for the treatment of uterine leiomyomas. Yonsei Med J 2002; 43: 346-350
15. Andersen PE, Lund N, Justesen P, Munk T, Elle B, Floridin C. Uterine artery embolization of symptomatic uterine fibroids. Acta Radiologica 2001; 42: 234-238
16. Hutchins FL, Worthington-Kirsch R, Berkowitz RP. Selective uterine artery embolization as primary treatment for symptomativ leiomyomata uteri. J Am Assoc Gynecol Laparosc 1999; 6: 279-284
17. Goodwin SC, McLucas B, Lee M, Chen GBS, Perrella R, Vedantham S, Muir S, Lai A, Sayre JW, DeLeon MBS. Uterine artery embolization for the treamtent of uterine leiomyomata midterm results. JVIR 1999; 10: 1159-1165
18. Siskin GP, Stainken BF, Dowling K, Meo PRN, Ahn J, Dolen EG. Outpatients uterine artery embolization for symptomatic uterine fibroids: experience in 49 patients. JVIR 2000; 11: 305-311
19. Spies JB, Ascher SA, Roth AR, Kim J, Levy E, Gomez-Jorge J. Uterine Artery Embolization for Leiomyomata. Obstet Gyn 2001; 98: 29-34
20. Watson GM, Walker WJ. Uterine artery embolisation for the treatment of symptomatic fibroids in 114 women: reduction in size of the fibroids and women's views of the sucess of the treatment. BJOG 2002; 109: 129-135
21. Meyer WR. Embolization of uterine fibroids. RSNA, Chicago 2001
22. Spies JB, Roth AR, Gonsalves SM, Murphy-Skrzyniarz KM. Ovarian function after uterine artery embolization for leiomyomata: assessment with use of follicle stimulating hormone assay. JVIR 2001; 12: 437-442
23. ACOG. Uterine artery embolization. Obstet Gynecol 2004; 103: 403-404
24. Vashist A, Studd J, Carey A, Burn P. Fatal septicaemia after fibroid embolisation. Lancet 1999; 354: 307
25. Lanocita R, Frigerio LF, Patelli G. A fatal complication of percutaneous transcatheder embolization for treatment of uterine fibroids Society of minimal invasive therapy, Boston, Mass 1999
26. De Blok S, de Vries C, Prinnsen HM, Bkaauwgeers HL, Jorna-Meijer L. Fatal sepsis after uterine artery embolization with microspheres. J Vasc Interv Radiol 2003; 14: 779-783
27. Makinen J, Johansson J, Tomas C, Heinonen PH, Laatikainen T, Kauko M, Heikkinen AM, Sjöberg J. Morbidity of 10110 hysterectomies by type of approach. Human Reprod 2001; 16: 1473-1478
28. ACOG Committee Opinion. Uterine artery embolizazion. Obstet Gynecol 2004; 103: 403-404
29. Goldberg J, Pereira L, Berghella V. Pregnancy after uterine artery embolization. Obstet Gynecol 2002; 100: 869-872
30. Shirk GJ. Minimally invasive surgery for ablation of the endometrium. Clin Obstet Gynecol 2005; 48: 325-336
31. Goldfarb HA. Combining myoma coagulation with endometrial ablation/resection reduces subsequent surgery rates. JSLS 2001; 5: 97-98
32. Soysal ME, Syosal SK, Vicdan K. Thermal balloon ablation in myoma-induced menorrhagia under local anesthesia. Gyn Obstet Invest 2001; 51: 128-133
33. Sowter MC, Lethaby A, Singla AA. Pre-operative endometrial thinning agents bifore endometrial destruction for heavy menstrual bleeding (Cochrane review). In: The Cochrane Library. Issue 4. ISSN 1464-780X 2005
34. Lethaby A, Hockey M, Garry R. Endometrial destruction techniques for heavy menstrual bleeding (Cochrane review). In: The Cochrane Library. Issue 4. ISSN 1464-780X 2005
35. Solnik JM, Guido RS, Sanfilippo JS, Krohn MA. The impact of endometrial ablation technique at a large university women's hospital. Am J Obstet Gynecol 2005; 193: 98-102
36. Hare AA, Olah KS. Pregnancy following endometrial ablation: a review artiche. J Obstet Gynecol 2005; 25: 108-114
37. Mukul LV, Linn JG. Pregnancy complicated by uterine synechiae after endometrial ablation. Obstet Gynecol 2005; 105: 1179-1182
38. Falcone T, Gustilo-Ashby AM. Minimally invasive surgery for mass lesions. Clin Obstet Gynecol 2005; 48: 353-360
39. Marziani R, Mossa B, Ebano V, Perniola G, Melluso J, Napolitano C. Transcervical hysteroscopic myomectomy: long-term effects on abnormal uterine bleeding. Clin Exp Obstet Gynecol 2005; 32: 23-26
40. Razavi MK, Hwang G, Jahed A, Modanloo S, Chen B. Abdominal myomectomy versus fibroid embolization in the treatment of symptomatic uterine leiomyomas. AJR 2003; 180: 1571-1575
41. Buttram VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 1981; 36: 433-445
42. Sawin SW, Pilevsky ND, Berlin JA, Barnhart KT. Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas. Am J Obstet Gynecol 2000; 183: 1448-1455
43. Dubuisson JB, Fauconnier A, Deffarges JV, Norgaard C, Kreiker G, Chapron C. Pregnancy outcome and deliveries following laparoscopic myomectomy. Hum Reprod 2000; 15: 869-873
44. Propst AM, Liberman RF, Harlow BL, Ginsburg ES. Complications of hysteroscopic surgery: predicting patients at risks. Obstet Gynecol 2000; 96: 517-520
45. Jansen FW, Vredevoogd CB, Van Ulzen K, Hermans J, Trimbos JB, Trimbos-Kemper TCM. Complications of Hysteroscopy: a prospective, multicenter study. Obstet Gynecol 2000; 96: 266-270
46. ACOG. Hysteroscopy. Obstet Gynecol 2005; 106: 439-442
47. Preutthipan S, Herahatya Y. Hysteroscopic polypectomy in 240 pre-menopausal and postmenopausal women. Fertil Steril 2005; 83: 705-509
48. Loffer FD. Improving results of hysteroscopic submucosal myomectomy for menorrhagia by concimitant endometrial ablation. J Minim Invasive Gynecol 2005; 12: 254-260
49. Crosignani PG, Vercellini P, Apolone G, De Giorni O, Cortesi I, Meschia M. Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. Am J Obstet Gynecol 1997; 177: 95-101
50. Khastgir G, Studd J. Patient's outlook, experience, and satisfaction with hysterectomy, bilateral oophorectomy, and subsequent continuation of hormone replacement therapy. Am J Obstet Gynecol 2000; 183: 1427-1433
51. Thakar R, Ayers S, Clarkson P, Stanton S, Manyonda I. Outcomes after total versus subtotal abdominal hysterectomy. N Engl J Med 2002; 347: 1318-1325
52. Okaro EO, Jones KD, Sutton C. Long term outcome following laparoscopic supracervical hysterectomy. BJOG 2001; 108: 1017-1020
53. Gaetje R. Organerhaltende Therapiemöglichkeiten beim Uterus myomatosus. Z Gyn 2004; 126: 119-124
54. Kujovich JL. Von Willebrand disease and menorrhagia; prevalence, diagnosis, and management. Am J Hematol 2005; 79: 220-228
55. Demers C, Derzko C, David M, Douglas J. Gynaecological and obstetrics management of women with inherited bleeding disorders. J Obstet Gynaecol 2005; 27: 707-732
56. Abu J, Davies Q, Ireland D. Should women with postcoital bleeding be referred to colposcopy? J Obstet Gynecol 2006; 26: 45-47
57. Shalina R, Amita S, Neera MA. How alarming is psot-coityl bleeding - a cytologic, colposcopic and histopathologic evaluation. Gynecol Obstet Invest 1998; 45: 205-208
58. Khattab AF, Ewies AA, Appleby D, Cruickshank DJ. The outcome of referral with postcoital bleeding (PCB). J Obstet Gynecol 2005; 35: 279-282